Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Corp Dev.&Strat. Officer
-
Stock Symbol
-
EYPT on Nasdaq
Michael Craig Pine - trading volume in the past year for EyePoint Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Restricted Stock Units |
30.6K |
$624K |
$20.40 |
Jan 6, 2024 |
Direct |
Common Stock |
|
Common Stock |
13.7K |
$342K |
$25.02 |
Jan 6, 2024 |
Direct |
|
|
Stock Option (Right to Buy) |
42K |
|
|
Jan 5, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.